Ana Igea
Impact in
- Cancer Research top 10%
- Molecular Biology top 10%
- Melanoma and MAPK Pathways
- RNA Research and Splicing
- RNA modifications and cancer
- Protein Kinase Regulation and GTPase Signaling
- DNA Repair Mechanisms
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
-
- Microtubule and mitosis dynamics 3
- Co-authors
- Ángel R. NebredaRaúl MéndezBegoña CánovasIván del Barco BarrantesJ. R. P. GuptaVassilis G. GorgoulisIgnacio DoladoIoannis S. Pateras
- Journals
- Nature Communications (3 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)Cancer Cell (2 papers)Molecular Therapy (1 paper)
- Partner nations
- SpainUnited KingdomGreece
In The Last Decade
Ana Igea
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 191
- Molecular Biology 793
- Oncology 260
- Cell Biology 116
- Pathology and Forensic Medicine 111
Countries citing papers authored by Ana Igea
This map shows the geographic impact of Ana Igea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Igea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Igea more than expected).
Fields of papers citing papers by Ana Igea
This network shows the impact of papers produced by Ana Igea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Igea. The network helps show where Ana Igea may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Igea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 28 | |
| 10 | 2019 | 114 | |
| 11 | 2018 | 70 | |
| 12 | 2017 | 12 | |
| 13 | 2016 | 64 | |
| 14 | 2016 | 50 | |
| 15 | 2015 | 24 | |
| 16 | 2014 | 140 | |
| 17 | 2013 | 72 | |
| 18 | 2013 | 52 | |
| 19 | 2013 | 119 | |
| 20 | 2011 | 2 |
About Ana Igea
Ana Igea is a scholar working on Oncology, Cell Biology, Molecular Biology, Immunology and Pathology and Forensic Medicine, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer Mechanisms and Therapy (3 papers), DNA Repair Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cell death mechanisms and regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (191 citations), Molecular Biology (793 citations), Oncology (260 citations), Cell Biology (116 citations) and Pathology and Forensic Medicine (111 citations). Ana Igea has collaborated with scholars based in Spain, United Kingdom and Greece. Frequent co-authors include Ángel R. Nebreda, Raúl Méndez, Begoña Cánovas, Iván del Barco Barrantes, J. R. P. Gupta, Vassilis G. Gorgoulis, Ignacio Dolado, Ioannis S. Pateras, Stratigoula Sakellariou and Mariano Maffei. Their work appears in journals such as Nature Communications, Frontiers in Immunology, Cancer Research, Cancer Cell and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.